Betta Pharmaceuticals Co., Ltd.

SZSE:300558 Rapport sur les actions

Capitalisation boursière : CN¥19.3b

Betta Pharmaceuticals Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Lieming Ding

Directeur général

CN¥2.9m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général11.3yrs
Propriété du PDG0.2%
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administration5yrs

Mises à jour récentes de la gestion

Recent updates

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Sep 30
Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 07
Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

Jul 30
Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

Apr 23
Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Apr 16
What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

PDG

Lieming Ding (61 yo)

11.3yrs

Titularisation

CN¥2,900,800

Compensation

Dr. Lieming Ding founded Betta Pharmaceuticals Co., Ltd.(also known as Zhejiang BetaPharma Co., Ltd) in 2002 and serves as its Chairman. Dr. Ding has been Chief Executive Officer and General Manager of Bet...


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Lieming Ding
Founderno dataCN¥2.90m0.24%
CN¥ 45.4m
Jianxun Fan
VP, CFO & Directorno dataCN¥1.46m0.031%
CN¥ 6.0m
Jiang Wan
Senior VP5yrsCN¥2.55m0.025%
CN¥ 4.8m
Jia Tong
Directorno dataCN¥1.46m0.039%
CN¥ 7.6m
Wei Wang
Independent Director5yrsCN¥120.00kpas de données
Cai Jiangnan
Independent Director5yrsCN¥120.00kpas de données
Yangnan Zhang
Chairman of the Supervisory Board & Senior Director of Project Declaration5yrsCN¥870.70kpas de données
Zhihua Yu
Director5yrspas de donnéespas de données
Tian Xu
Director2.1yrspas de donnéespas de données
Fei Wu
Supervisorno dataCN¥860.20kpas de données
Jiajia Xiao
Independent Director2.1yrsCN¥120.00kpas de données
Rong Wang
Shareholder Supervisor1.9yrspas de donnéespas de données

5.0yrs

Durée moyenne de l'emploi

56.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 300558 sont considérés comme expérimentés (ancienneté moyenne 5 ans).